Orphan Drug Designation Provided to a Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
source: pixabay.com

Orphan Drug Designation Provided to a Treatment for Chronic Inflammatory Demyelinating Polyneuropathy

The FDA has just provided Orphan Drug Designation to Hizentra for the treatment of adults diagnosed with chronic inflammatory demyelinating polyneuropathy (CIPD). This is a maintenance therapy which works to…

Continue Reading Orphan Drug Designation Provided to a Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
Scientists Find That Rubella and Certain Cancers Have the Same Mutation Mechanisms
source: pixabay.com

Scientists Find That Rubella and Certain Cancers Have the Same Mutation Mechanisms

By Danielle Bradshaw from In The Cloud Copy Scientific teams at the Centers for Disease Control (CDC), the National Institute of Environmental Health Sciences (NIEHS), and other research centers have…

Continue Reading Scientists Find That Rubella and Certain Cancers Have the Same Mutation Mechanisms

Breakthrough Therapy Designation Given to Investigative WHIM Syndrome Treatment

WHIM Syndrome WHIM syndrome is a form of primary immunodeficiency. It is caused by a mutation in the CXCR4 gene. WHIM stands for Warts, Hypogammaglobulinemia, Infections, and Myelokathexis. Throughout their…

Continue Reading Breakthrough Therapy Designation Given to Investigative WHIM Syndrome Treatment

PID Patients Could Receive More Personalized Treatment Thanks to New Study

A New Study A recent study published in Nature Immunology and conducted by researchers at the University of Basel has produced influential results regarding primary immunodeficiency disorders (PID). These rare disorders…

Continue Reading PID Patients Could Receive More Personalized Treatment Thanks to New Study
Two Best Friends With Primary Immunodeficiency Meet for the First Time in Cape Town, South Africa
Olichel / Pixabay

Two Best Friends With Primary Immunodeficiency Meet for the First Time in Cape Town, South Africa

According to a story from Cape Town Etc, two girls in South Africa were living with the same rare disease: primary immunodeficiency (PI), a group of rare conditions in which…

Continue Reading Two Best Friends With Primary Immunodeficiency Meet for the First Time in Cape Town, South Africa
More than 4% of People May be Immunocompromised – How Should They Approach Flu Season?
source: pixabay.com

More than 4% of People May be Immunocompromised – How Should They Approach Flu Season?

A recent publication from Healio detailed some of the challenges immunocompromised individuals might face during flu season. Influenza is a common and sometimes serious public health concern around the world, and…

Continue Reading More than 4% of People May be Immunocompromised – How Should They Approach Flu Season?
Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients
qimono / Pixabay

Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients

A recent publication from Specialty Pharmacy Times noted that the rapidly-growing number of available human immunoglobulin treatments for primary immunodeficiency disorders could pose challenges for specialty pharmacists when treating patients.…

Continue Reading Specialty Pharmacists Play Important Role in Treatment of Primary Immunodeficiency Patients
Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk
stanvpetersen / Pixabay

Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk

According to a story from the Warwick Beacon, the first ever primary immunodeficiency (PI) awareness and fundraising walk in Rhode Island's history was held recently at Warwick City Park. The…

Continue Reading Five Month Old Patient in the Spotlight for Primary Immunodeficiency Walk

Enrollment Opens for Phase 3 Study of Intravenous Immunoglobulin in Primary Immunodeficiency Patients

According to a publication from BioSpace, New Jersey-based Kedrion Biopharma recently announced the enrollment of the first participant in their CARES10 study. CARES10 is a phase 3 study of a…

Continue Reading Enrollment Opens for Phase 3 Study of Intravenous Immunoglobulin in Primary Immunodeficiency Patients
Primary Immunodeficiency in Children: Early Intervention is Important
RachelBostwick / Pixabay

Primary Immunodeficiency in Children: Early Intervention is Important

According to a story from The Indian Express, early treatment and diagnosis of primary immunodeficiencies makes management of this group of disease much simpler as a whole. In children, the…

Continue Reading Primary Immunodeficiency in Children: Early Intervention is Important